Skip to content
Skip to main menu
About Us
CEO Message
Mission & Vision
History
Leadership
Products
Overview
OncoField Lab
DeepField A460
iField-PL150
iMET System
FieldGen
Pipeline
Technology
iMPACT technology
Preclinical Studies
R&D
Community
Press Releases
Announcements
FAQ
Contact
Downloads
Privacy Policy
EN
KR
EN
Innovative Cancer Care Solutions
FieldCure — a biotechnology company advancing new cancer treatment technologies
Pipeline
Overview
Products
▾
Treatment planning software
OncoField Lab
Therapeutic devices
DeepField A460
iField-PL150
iMET System
Research systems
FieldGen
Pipeline
Pipeline
Product
H2 2025
H1 2026
H2 2026
H1 2026
H2 2026
H1 2027
H2 2027
iField-PL150
Diathermy device
Pain reduction
Commercial use
MFDS approval in March 2025
Commercial Use
DeepField A460
RF hyperthermia device
For use in accordance with the approved labelling
Available
MFDS approval in Sep 2025
Commercial Use
iMET System
Electric field cancer therapy system
In development for pancreatic and rare cancers
Preparing for clinical trials
Designated as Innovative
Medical Device in Sep 2025
Planned Clinical Trial